UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 565

Sortiert nach

Cancer chemoprevention: a rapidly evolving field

British journal of cancer, 2013-07, Vol.109 (1), p.1-7

2013

Volltextzugriff (PDF)

Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials

Annals of oncology, 2014-12, Vol.25 (12), p.2425-2432

2014

Volltextzugriff (PDF)

Curcumin: The story so far

European journal of cancer (1990), 2005-09, Vol.41 (13), p.1955-1968

2005

Volltextzugriff (PDF)

Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration

British journal of cancer, 2004-03, Vol.90 (5), p.1011-1015

2004

Volltextzugriff (PDF)

Molecular prognostic markers in pancreatic cancer: A systematic review

European journal of cancer (1990), 2005-10, Vol.41 (15), p.2213-2236

2005

Volltextzugriff (PDF)

Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene

British journal of cancer, 2004-02, Vol.90 (3), p.736-744

2004

Volltextzugriff (PDF)

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

British journal of cancer, 2000-04, Vol.82 (8), p.1427-1432

2000

Volltextzugriff (PDF)

Cellular and plasma uptake of parenteral omega-3 rich lipid emulsion fatty acids in patients with advanced pancreatic cancer

Clinical nutrition (Edinburgh, Scotland), 2014-10, Vol.33 (5), p.895-899

2014

Volltextzugriff (PDF)

Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis

British journal of cancer, 2007-01, Vol.96 (2), p.248-254

2007

Volltextzugriff (PDF)

Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies

European journal of cancer (1990), 2005, Vol.41 (1), p.61-70

2005

Volltextzugriff (PDF)

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

British journal of cancer, 2003-07, Vol.89 (2), p.252-257

2003

Volltextzugriff (PDF)

Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases

European journal of cancer (1990), 2009-01, Vol.45 (1), p.56-64

2009

Volltextzugriff (PDF)

Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo

British journal of cancer, 2004-10, Vol.91 (7), p.1364-1371

2004

Volltextzugriff (PDF)

Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics

Cancer prevention research (Philadelphia, Pa.), 2011-09, Vol.4 (9), p.1419-1425

2011

Volltextzugriff (PDF)

Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies

European journal of cancer (1990), 2006-09, Vol.42 (14), p.2318-2325

2006

Volltextzugriff (PDF)

The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study

Annals of oncology, 2007-06, Vol.18 (6), p.1098-1103

2007

Volltextzugriff (PDF)

The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease

European Journal of Cancer, 2000-01, Vol.36 (2), p.151-169

2000

Volltextzugriff (PDF)

Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials

Annals of oncology, 2005-04, Vol.16 (4), p.558-565

2005

Volltextzugriff (PDF)

Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity

British journal of cancer, 2003-12, Vol.89 (12), p.2271-2276

2003

Volltextzugriff (PDF)

A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging

British journal of cancer, 2006-05, Vol.94 (10), p.1420-1427

2006

Volltextzugriff (PDF)

Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: Modification by dietary curcumin and implications for clinical trials

European journal of cancer (1990), 2006-02, Vol.42 (3), p.415-421

2006

Volltextzugriff (PDF)

Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients

Journal of clinical oncology, 1998-02, Vol.16 (2), p.642-650

1998

Volltextzugriff (PDF)

Role of inflammation in pancreatic carcinogenesis and the implications for future therapy

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2005-01, Vol.5 (6), p.514-529

2005

Volltextzugriff (PDF)

Marimastat (BB2516) : Current status of development

Cancer chemotherapy and pharmacology, 1999, Vol.43 (7), p.S56-S60

STEWARD, W. P

1999

Volltextzugriff (PDF)

A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer

British journal of cancer, 2002-07, Vol.87 (1), p.15-20

2002

Volltextzugriff (PDF)

1 – 25 von 565

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(505)
Mit Volltextzugriff
(497)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(368)
Life Sciences & Biomedicine
(328)
Humans
(297)
Biological And Medical Sciences
(185)
Female
(173)
Male
(167)
Medical Sciences
(154)
Oncology
(153)
Middle Aged
(130)
Adult
(111)
Aged
(99)
Animals
(95)
Pharmacology. Drug Treatments
(74)
Tumors
(66)
Antineoplastic Agents
(51)
Chemotherapy
(49)
Adolescent
(46)
Mice
(45)
Treatment Outcome
(40)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(38)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cancer chemoprevention: a rapidly evolving field

Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials

Curcumin: The story so far

Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration

Molecular prognostic markers in pancreatic cancer: A systematic review

Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

Cellular and plasma uptake of parenteral omega-3 rich lipid emulsion fatty acids in patients with advanced pancreatic cancer

Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis

Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases

Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo

Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics

Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies

The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study

The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease

Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials

Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity

A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging

Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: Modification by dietary curcumin and implications for clinical trials

Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients

Role of inflammation in pancreatic carcinogenesis and the implications for future therapy

Marimastat (BB2516) : Current status of development

A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer

Suchergebnisse filtern